Jump to content

 

 

Next-Generation Bioprocess Development. Today.

Genedata Bioprocess® empowers bio-manufacturing by integrating and harmonizing bioprocess development and CMC workflows across CLD, USP and DSP, formulation, and analytics. The platform is used by biopharmas and CMOs worldwide to digitalize development operations and enforce data integrity and compliance.

 

 

Our Customers

Watch this four-minute video introducing the only platform that integrates and centrally manages all data along biopharma development and CMC workflows, unleashing the power to digitally trace every molecule, sample, result, and process.

Purpose-built. Digitalizing Next-Generation Process Design.

Achieve operational excellence with the only platform uniquely built for the development of biotherapeutic drugs. Acting as a structured data backbone that integrates across biopharma workflows and automates lab instruments and robotics stations, Genedata Bioprocess ensures maximal efficiency along the whole end-to-end workflow. The platform supports cutting-edge technologies, such as highly parallel scale-down bioreactor panels, as well as complex DSP unit operations and sophisticated analytical techniques. Users at all levels of an organization get real-time access to all relevant data to enable data-driven decisions that empower R&D.

More About Bioprocess
In two minutes, find out how Genedata Bioprocess directly integrates with all laboratory instruments to automate data capture.

Automate & Industrialize.
Improve Productivity.

By directly integrating with all laboratory instruments, such as bioreactors, downstream processing equipment, and analytics devices, Genedata Bioprocess automates data capture, which dramatically improves overall productivity and reduces manual errors. The platform can also be integrated with robotics equipment, enabling full automation and high-throughput processes, such as HT formulation screens.

CGT Bioprocess Development

  • Supports bioprocess development for all biotherapeutic modalities including proteins, adoptive cells, recombinant viruses, and RNAs
  • Establishes next-generation biomanufacturing processes across cell line development, upstream processing, downstream processing, formulation, and analytics development
  • Includes thorough tracking and rigorous characterization of the relationship between critical quality attributes and critical process parameters
  • Simplifies analytical development through a centralized approach to capturing and analyzing data from all instruments and assays to assess process parameters and product quality
  • Integrates laboratory devices (e.g., bioreactors, chromatography skids, and liquid handling systems) for efficient data transfer and automation
More About CGTs

RNA Development. Structured. E2E.

  • Tracks and integrates data during process development for nucleic acid therapeutics (USP, DSP and formulation), end-to-end
  • Facilitates identification and registration of critical quality attributes (CQAs), critical process parameters (CPPs) and critical material attributes (CMAs) during all production steps (e.g., in vitro transcription)
  • Enforces data integrity in complex formulations using automatic uniqueness validation
  • Ensures seamless data and material transfer between departments using an integrated request management system
More About RNAs

Set Up HT Development Processes

  • Automates and scales up cloning, screening, engineering, expression, and purification of vaccine candidates and their components
  • Enables well-organized bioprocess development (USP, DSP, formulation, and analytics) for all vaccine types including support for synthetic and cell-free processes 
  • Integrates all lab instruments and robotic devices via open architecture to automate data transfer, e.g., during formulation screening
  • Facilitates automated communication and transparent handover of materials and data between different teams and functions
More About Vaccines

Customer Stories

Watch this two-minute video showing how Sartorius uses Genedata as a central repository and automation platform to digitalize and streamline operations.

Pharmaceutical giants as well as renowned CMOs around the world use Genedata Bioprocess to increase the efficiency of their development processes. Renowned CMO Sartorius Stedim Biotech implemented Genedata Bioprocess to fully digitalize their laboratory workflows. As Sartorius moved from spreadsheets to automated data handling, they enabled complete digital traceability and automation of their bioprocess development operations. The result - an increase in overall productivity by a factor of 3.

Conference Presentations

More Customer Presentations

Genedata's customers at leading biopharmaceutical and biotech companies worldwide regularly present how Genedata Bioprocess is used to advance their R&D activities. Learn how Pfizer, Bayer, Sanofi, Celgene and others are streamlining processes and increasing efficiency of their biotherapeutic development operations with the Genedata platform.
 

Learn More
Biopharma Partner Symposium

Meet the Genedata Community

Genedata Biopharma Partner Symposium
March 6–7, 2024 | Basel, Switzerland

At the Genedata Biopharma Partner Symposium, leading biopharma, biotech, and CRO/CDMO companies show how groups have set up, operate, and use Genedata solutions to transform their biotherapeutics activities and how this results in increased efficiency and throughput. Presentations and discussions focus on innovative applications and new industry scientific and IT requirements including novel molecular formats (e.g., multispecifics, TCRs, CARs, AAVs, RNA vaccines), advanced screening technologies, MS-based multi-attribute methods (MAM), NGS, molecular patient profiling, and automation and data FAIRification in biopharmaceutical R&D.

Learn More

   
 

Empower Your Biopharma Development Today

Request More Information